Literature DB >> 7958020

Activation and suppression of fibroblast function.

P T Khaw1, N L Occleston, G Schultz, I Grierson, M B Sherwood, G Larkin.   

Abstract

The fibroblast is the central player in the wound repair and scarring processes that occur in the anterior segment of the eye. Glaucoma filtration surgery is the ultimate example of the importance of the wound healing process, as this process is the major determinant of the success of this procedure. We highlight the role of the fibroblast, and discuss some of the growth factors stimulating fibroblast proliferation, migration and extracellular matrix production in the wound environment. We also review current methods of suppressing fibroblast proliferation, the new concepts that have arisen from laboratory studies, and future directions of investigation and treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7958020     DOI: 10.1038/eye.1994.44

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  36 in total

Review 1.  Recent advances: ophthalmology.

Authors:  A R Fielder; C Bentley; M J Moseley
Journal:  BMJ       Date:  1999-03-13

2.  Gene therapy: new "magic bullets" to prevent ocular scarring.

Authors:  P T Khaw; A D Cambrey; G A Limb; J T Daniels
Journal:  Br J Ophthalmol       Date:  2002-05       Impact factor: 4.638

3.  Proliferative response of cultured human tenon's capsule fibroblasts to platelet-derived growth factor isoforms.

Authors:  M Knorr; M Völker; P O Denk; K Wunderlich; H J Thiel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-10       Impact factor: 3.117

4.  Decorin and suramin inhibit ocular fibroblast collagen production.

Authors:  H Mietz; P Chévez-Barrios; M W Lieberman; M Wendt; R Gross; S F Basinger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

5.  New model of conjunctival scarring in the mouse eye.

Authors:  M B Reichel; M F Cordeiro; R A Alexander; I A Cree; S S Bhattacharya; P T Khaw
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

Review 6.  Impact of the clinical use of ROCK inhibitor on the pathogenesis and treatment of glaucoma.

Authors:  Megumi Honjo; Hidenobu Tanihara
Journal:  Jpn J Ophthalmol       Date:  2018-02-14       Impact factor: 2.447

7.  Postoperative adjunctive bevacizumab versus placebo in primary trabeculectomy surgery for glaucoma.

Authors:  Sana' Muhsen; Javiera Compan; Tze Lai; Christoph Kranemann; Catherine Birt
Journal:  Int J Ophthalmol       Date:  2019-10-18       Impact factor: 1.779

8.  Effects of octreotide acetate and amniotic membrane on wound healing in experimental glaucoma surgery.

Authors:  Tamer Demir; Burak Turgut; Ulku Celiker; Ibrahim Ozercan; Fatih Ulas; Nuray Akyol
Journal:  Doc Ophthalmol       Date:  2003-09       Impact factor: 2.379

9.  MMP inhibition prevents human lens epithelial cell migration and contraction of the lens capsule.

Authors:  T T L Wong; J T Daniels; J G Crowston; P T Khaw
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

10.  Cationic nano-copolymers mediated IKKbeta targeting siRNA inhibit the proliferation of human Tenon's capsule fibroblasts in vitro.

Authors:  Yongheng Duan; Xipeng Guan; Jian Ge; Daping Quan; Yehong Zhuo; Hehua Ye; Tingting Shao
Journal:  Mol Vis       Date:  2008-12-31       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.